<DOC>
	<DOCNO>NCT03088150</DOCNO>
	<brief_summary>The primary objective prove non-inferiority thermal ablation compare hepatic resection patient least one resectable ablatable colorectal liver metastasis ( ≤3cm ) extrahepatic disease .</brief_summary>
	<brief_title>COLLISION Trial - Colorectal Liver Metastases : Surgery v Thermal Ablation</brief_title>
	<detailed_description>Study design : COLLISION single-blind prospective multi-center phase-III randomize controlled trial . We hypothesize thermal ablation non-inferior surgery select patient group term primary objective ( overall survival ) . The Cox proportional hazard model ( 1-sided ; non-inferiority superiority ) use sample size calculation . Given superior safety profile consider hazard ratio 1.3 represent upper limit non-inferiority ( non-inferiority margin ) . An HR 1.3 correspond 56.5 % chance ablate patient die first ( ( P = HR/ ( 1 + HR ) = 1.3/ ( 1 + 1.3 ) = 0.565 ( 56.5 % ) ) . With 3 year patient accrual five year follow-up reach 60 % event ( death ) approximately 6.5 year ( overall probability event , pE =0.6 ) . The calculated sample size therefore 599 ( NS ) .To account 10 % drop-out ratio ( NDO=69 ) prior randomization 3 % loss follow-up ( NLTFU=18 ) randomization need include 687 patient ( NI ) . A total number 618 patient randomize ( NR ) one two arm : arm A undergo surgical resection ( n=309 ) arm B thermal ablation ( n=309 ) appoint target lesion . Study population : Patients ≥1 resectable ablatable CRLM ( ≤3cm ) , extrahepatic disease , good performance status ( WHO 0-2 ) low-risk clinical risk score ( CRS 0-2 ) consider eligible . Supplementary resection resectable lesion &gt; 3cm thermal ablation unresectable CRLM ≤3cm allow maximum number CRLM 10 . Intervention : Eligible patient stratify low- , intermediate- high disease burden assessment expert panel . The panel , consist least two diagnostic radiologist , two interventional radiologist two hepatobiliary and/or oncological surgeon , appoint lesion resectable ablatable target lesion , resectable unablatable lesion unablatable lesion ablatable unresectable lesion unresectable lesion . All unablatable lesion resectable unresectable lesion ≤3cm ablatable . With exception patient suitable laparoscopic resection percutaneous ablation ( low disease burden ) , eligibility need reconfirm surgical procedure . Hereafter patient randomize undergo surgical resection target lesion ( allow thermal ablation additional unresectable lesion ) thermal ablation ( allow resection additional unablatable lesion ) . Patients remain unaware appoint treatment arm actual treatment target lesion ( single-blind ) . Postprocedural care identical two group exemption hepatic recurrence ( either local site recurrence new lesion ) suitable resection ablation treat technique use treat initial target lesion ( ) . Conferring national guideline follow-up include contrast-enhanced ( ce ) CT scan , 18F-FDG-PET-CT scan , laboratory test include tumor marker ( CEA ) quality life questionnaire . Patients recurrence consider unsuitable additional focal therapy re-referred medical oncologist ass additional systemic chemotherapy . In event chemotherapeutic down-staging hereafter , focal therapy reconsider .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Participant inclusion criterion , example : Age 18 year Life expectancy least 12 week Adequate blood sample Written inform consent Histological documentation primary colorectal tumor Participant exclusion criterion , example : No target lesion suitable resection ablation The presence extrahepatic nodal nonnodal metastasis Pregnant breastfeeding subject Other therapy given/done prior procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hepatic resection</keyword>
	<keyword>Liver surgery</keyword>
	<keyword>Thermal ablation</keyword>
	<keyword>Radiofrequency ablation</keyword>
	<keyword>Microwave ablation</keyword>
	<keyword>RFA</keyword>
	<keyword>MWA</keyword>
</DOC>